With Tirzepatide (marketed as Zepbound by Eli Lilly) removed from the FDAs drug shortage list, providers using compounded versions for off-label weight loss are now at risk
Sagvolden T, Russell VA, Aase H, Johansen EB, Farshbaf M
40(1): 320 Prescott LF
Hidese, S., Ogawa, S., Ota, M., Ishida, I., Yasukawa, Z., Ozeki, M., & Kunugi, H
No drug can fix this situation, but neurotoxin removal is the logical, more strategic solution
For substances that trend quickly online, especially those sold in loosely regulated or unregulated markets, like injectable peptides, patient discussions on platforms like Reddit and TikTok may offer one of the earliest clues to what users are actually experiencing